查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1317679

給藥市場：口服給藥、設備類型、分銷管道、用途- 全球預測 2023-2030

Drug Delivery Market by Oral Drug Delivery, Device Type, Distribution Channels, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球給藥市場預計將大幅成長，預計2023年將達到172,009萬美元，年複合成長率為6.38%，2030年將達到265896萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球給藥市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 全球給藥市場規模與預測是多少？

2.在預測期內，COVID-19對全球給藥市場的阻礙因素與影響為何？

3. 在預測期內，全球給藥市場需要投資哪些產品/細分市場/應用/領域？

4.全球給藥市場的競爭策略是什麼？

5. 全球給藥市場的技術趨勢和法律規範是什麼？

6. 全球給藥市場主要供應商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入全球給藥市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 世界各地生物藥物的使用增加
      • 對有效藥物輸送機制的需求不斷成長
      • 慢性病顯著增加
    • 抑制因素
      • 藥品召回和藥品失效的增加
      • 與藥物相關的副作用和風險
    • 機會
      • 對具有成本效益的醫療保健治療的需求不斷成長
      • 越來越關注居家照護和自我管理
    • 任務
      • 價格壓力與專利到期問題
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 口服給藥給藥市場

  • 注射給藥
  • 鼻腔給藥
  • 眼科藥物輸送
  • 肺部藥物輸送
  • 流行的藥物輸送

第7章 依設備類型分類的藥物輸送市場

  • 高度
  • 傳統的

第8章 按分銷管道分類的給藥市場

  • 醫院藥房
  • 零售藥房

第9章 藥物輸送市場：依用途

  • 癌症
  • 心血管疾病
  • 糖尿病
  • 呼吸系統疾病

第10章 美洲給藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太藥物傳輸市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲給藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-434CCDA0515A

The Global Drug Delivery Market is forecasted to grow significantly, with a projected USD 1,720.09 million in 2023 at a CAGR of 6.38% and expected to reach a staggering USD 2,658.96 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Delivery Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Delivery Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Oral Drug Delivery, market is studied across Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, and Topical Drug Delivery. The Injectable Drug Delivery is projected to witness significant market share during forecast period.

Based on Device Type, market is studied across Advanced and Conventional. The Conventional is projected to witness significant market share during forecast period.

Based on Distribution Channels, market is studied across Hospital Pharmacies and Retail Pharmacies. The Hospital Pharmacies is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cancer, Cardiovascular Diseases, Diabetes, and Respiratory Diseases. The Diabetes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 35,944.71% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Delivery Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Delivery Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Delivery Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Delivery Market?

4. What is the competitive strategic window for opportunities in the Global Drug Delivery Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Delivery Market?

6. What is the market share of the leading vendors in the Global Drug Delivery Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Delivery Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Delivery Market, by Oral Drug Delivery, 2022 vs 2030
  • 4.3. Drug Delivery Market, by Device Type, 2022 vs 2030
  • 4.4. Drug Delivery Market, by Distribution Channels, 2022 vs 2030
  • 4.5. Drug Delivery Market, by Application, 2022 vs 2030
  • 4.6. Drug Delivery Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of biological drugs worldwide
      • 5.1.1.2. Swelling demand for effective drug delivery mechanisms
      • 5.1.1.3. Significant increase in chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing drug recalls and drug failures
      • 5.1.2.2. Side effects and risk associated with the drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for cost-effective healthcare treatment
      • 5.1.3.2. Growing focus towards home care and self-administration
    • 5.1.4. Challenges
      • 5.1.4.1. Pricing pressure and issues with patents expiry
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Delivery Market, by Oral Drug Delivery

  • 6.1. Introduction
  • 6.2. Injectable Drug Delivery
  • 6.3. Nasal Drug Delivery
  • 6.4. Ocular Drug Delivery
  • 6.5. Pulmonary Drug Delivery
  • 6.6. Topical Drug Delivery

7. Drug Delivery Market, by Device Type

  • 7.1. Introduction
  • 7.2. Advanced
  • 7.3. Conventional

8. Drug Delivery Market, by Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Retail Pharmacies

9. Drug Delivery Market, by Application

  • 9.1. Introduction
  • 9.2. Cancer
  • 9.3. Cardiovascular Diseases
  • 9.4. Diabetes
  • 9.5. Respiratory Diseases

10. Americas Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Delivery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DELIVERY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2022 VS 2030 (%)
  • FIGURE 5. DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2022 VS 2030 (%)
  • FIGURE 6. DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2022 VS 2030 (%)
  • FIGURE 7. DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. DRUG DELIVERY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. DRUG DELIVERY MARKET DYNAMICS
  • FIGURE 10. DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG DELIVERY MARKET SIZE, BY INJECTABLE DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG DELIVERY MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG DELIVERY MARKET SIZE, BY PULMONARY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG DELIVERY MARKET SIZE, BY TOPICAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG DELIVERY MARKET SIZE, BY ADVANCED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG DELIVERY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG DELIVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG DELIVERY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. DRUG DELIVERY MARKET LICENSE & PRICING